Institutional shares held 79.9 Million
1.08M calls
2.73M puts
Total value of holdings $211M
$2.85M calls
$7.21M puts
Market Cap $1.03B
400,304,000 Shares Out.
Institutional ownership 19.96%
# of Institutions 239


Latest Institutional Activity in IBRX

Top Purchases

Q1 2025
Vanguard Group Inc Shares Held: 20.3M ($52.3M)
Q1 2025
Citigroup Inc Shares Held: 2.71M ($6.98M)
Q1 2025
Octagon Capital Advisors LP Shares Held: 1.72M ($4.42M)
Q1 2025
Group One Trading, L.P. Shares Held: 1.35M ($3.46M)
Q1 2025
Verition Fund Management LLC Shares Held: 827K ($2.13M)

Top Sells

Q1 2025
State Street Corp Shares Held: 7.58M ($19.5M)
Q1 2025
Morgan Stanley Shares Held: 1.9M ($4.87M)
Q1 2025
Tang Capital Management LLC Shares Held: 2.33M ($6M)
Q1 2025
Rafferty Asset Management, LLC Shares Held: 325K ($834K)
Q1 2025
Ubs Group Ag Shares Held: 1.44M ($3.7M)

About IBRX

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.


Insider Transactions at IBRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
118M Shares
From 6 Insiders
Exercise of conversion of derivative security 523K shares
Conversion of derivative security 117M shares
Sell / Disposition
184K Shares
From 5 Insiders
Payment of exercise price or tax liability 184K shares

Track Institutional and Insider Activities on IBRX

Follow ImmunityBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

News

Receive news related to ImmunityBio, Inc.

Track Activities on IBRX